Showing results (211-220 of 10,874) with videos related to
Sort By:
Pageof 1,088
Breast Cancer Research and Treatment|May 10, 2011
Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trialsWen-Bin Zhou, Qiang Ding, Ling Chen, et al.Breast Cancer Research and Treatment|May 25, 2011
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancerAtanas Ignatov, Tanja Ignatov, Christine Weissenborn, et al.Breast Cancer Research and Treatment|April 1, 2011
LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosisZhi-Yu Wang, Tjing Yung Loo, Jian-Gang Shen, et al.Breast Cancer Research and Treatment|April 1, 2011
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypesG Cancello, P Maisonneuve, N Rotmensz, et al.Breast Cancer Research and Treatment|March 17, 2011
PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapyPawel Domagala, Tomasz Huzarski, Jan Lubinski, et al.Breast Cancer Research and Treatment|April 12, 2011
A signature of immune function genes associated with recurrence-free survival in breast cancer patientsMaria Libera Ascierto, Maciej Kmieciak, Michael O Idowu, et al.Breast Cancer Research and Treatment|May 27, 2011
Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancerJuan Zhang, Renguang Pei, Zhiyuan Pang, et al.Breast Cancer Research and Treatment|May 27, 2011
Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expressionSharon Hensley Alford, Katherine Toy, Sofia D Merajver, et al.Breast Cancer Research and Treatment|May 27, 2011
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypesJord H A Nagel, Justine K Peeters, Marcel Smid, et al.Breast Cancer Research and Treatment|June 10, 2011
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trialSirwan Hadad, Takayuki Iwamoto, Lee Jordan, et al.Pageof 1,088